回肠或结肠组织学活动与内镜缓解克罗恩病患者的临床复发无关
本研究基于单中心注册数据库,纳入129例内镜下缓解(SES-CD<3)的克罗恩病患者,对192份活检(回肠90份、结肠102份)进行组织学分级,发现组织学活动与2年内临床复发无显著关联,提示组织学愈合并非临床复发的独立预测因素。
要点
- 内镜缓解的CD患者中,组织学活动与2年内临床复发无显著关联。
- 回肠和结肠的组织学活动、静止期及正常组织学各组复发率无差异。
- 组织学活动与症状评分(HBI、SIBDQ)之间无关联。
核心结论
- 在内镜和临床缓解的克罗恩病患者中,组织学缓解与2年内临床复发无关。
研究设计与样本
- 单中心注册研究,纳入129例内镜缓解(SES-CD<3)的克罗恩病患者,平均年龄25岁,平均病程14.5年,女性占46.5%。
- 对192份活检(回肠90份、结肠102份)进行组织学分级,分为活动期、静止期和正常组织学。
- 主要结局为2年内临床复发(剂量升级、治疗改变、需全身激素、CD相关住院或手术)。
- 采用多因素回归调整混杂因素,评估组织学活动的独立预测价值。
主要发现
- 2年内42例(32.6%)发生临床复发。
- 线性回归分析未发现回肠活检组织学活动特征与症状评分(Harvey Bradshaw指数和简单IBD问卷评分)相关。
关键数值与推荐
- 内镜缓解定义为简单内镜评分(SES-CD)低于3。
- 组织学活动定义为存在隐窝破坏、中性粒细胞、糜烂或溃疡。
- 组织学静止期定义为存在结构扭曲和慢性炎症浸润。
- 正常组织学定义为无上述任何特征。
临床怎么用
- 对于已达到内镜缓解的克罗恩病患者,组织学活动可能不必要作为调整治疗的依据。
- 临床决策应主要基于内镜缓解和临床症状,而非组织学愈合。
局限性
- 单中心注册研究,样本量有限(129例),可能影响结论的普遍性。
- 组织学分级和活检取样存在一定的主观性和采样误差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Goals of treatment for Crohn's disease (CD) are clinical and endoscopic remission. It is not clear whether histologic markers of healing associate with endoscopic remission in patients with CD. METHODS: We identified patients with CD from a single institutional registry, and collected data from 129 patients (46.5% female; mean age 25 y; mean CD duration 14.5 y) who underwent colonoscopy evaluation and had simple endoscopic scores for CD below 3 (the definition of endoscopic remission). Histologic signs of CD activity were graded in 192 biopsies (90 ileum and 102 colon), and disease was classified as active (presence of crypt destruction, neutrophils, erosions or ulcerations), quiescent (presence of architectural distortion and chronic inflammatory infiltrate), or normal histology (none of these). The primary outcome was clinical relapse within 2 y (dose escalation, change in therapy, need for systemic steroids, or CD-related hospitalization or surgery). We performed multivariable regression adjusting for relevant confounders to examine the independent predictive value of histologic activity. RESULTS: Within 2 y of endoscopic evaluation, 42 patients (32.6%) had a clinical relapse. There were no significant differences in proportions of patients with active ileal CD (23.8%), quiescent CD (28.6%), or normal histology (37%) between those who relapsed and those remaining in remission (P = .43). There were no significant differences in proportions of relapses among patients with active colonic disease (38.1%), quiescent disease (35.0%), or normal histology (27.9%, P = .73). A linear regression analysis found no association between histologic features of active disease in ileal histology biopsies and symptom scores (Harvey Bradshaw index and simple inflammatory bowel disease questionnaire scores). CONCLUSIONS: In an analysis of biopsies from patients with CD who had achieved clinical and endoscopic remission, histologic remission was not associated with clinical relapse within 2 years.
引用
- Hu AB, Tan W, Deshpande V, et al. Ileal or Colonic Histologic Activity Is Not Associated With Clinical Relapse in Patients With Crohn's Disease in Endoscopic Remission. Clin Gastroenterol Hepatol. 2020. PMID: 32360823. doi:10.1016/j.cgh.2020.04.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。